GPX4 and cancer: For instance, cancer cells treated with palladium pyrithione complex (PdPT), which acts as a pan-deubiquitinase (pan-DUB) inhibitor, experience apoptosis and ferroptosis characterized by caspase activation and degradation of the GPX4 protein [172].